Quality & Standards

Understanding ISO 8362-1 Compliance for Sterile Glass Vials

Core Distro TeamJuly 10, 2026
Understanding ISO 8362-1 Compliance for Sterile Glass Vials

What Is ISO 8362-1?

ISO 8362-1:2018 (Injection containers and accessories — Part 1: Injection vials made of borosilicate glass) is the international standard that specifies the form, dimensions, material, performance, and packaging requirements for glass vials intended for parenteral (injectable) preparations.

For 503A and 503B compounding pharmacies, sourcing vials that comply with ISO 8362-1 is not optional — it is a fundamental requirement for ensuring patient safety and regulatory compliance.

Scope of the Standard

ISO 8362-1 covers:

  1. Glass type classification (Type I borosilicate)
  2. Dimensional requirements (external diameter, height, neck finish)
  3. Capacity designations (nominal and brimful volumes)
  4. Glass quality requirements (hydrolytic resistance, chemical durability)
  5. Visual defects (bubbles, inclusions, surface imperfections)
  6. Mechanical strength (thermal shock resistance, internal pressure)

Key Requirements Explained

Glass Type I Borosilicate

ISO 8362-1 mandates Type I borosilicate glass, which offers:

  • High hydrolytic resistance (< 1.0 ml 0.01M HCl per gram of glass grains)
  • Low alkali release preventing pH shifts in drug solutions
  • Excellent thermal shock resistance (withstands ΔT > 120°C)
  • Chemical inertness compatible with most pharmaceutical formulations

The borosilicate composition typically contains:

  • SiO₂: 70–80%
  • B₂O₃: 7–13%
  • Na₂O + K₂O: 4–8%
  • Al₂O₃: 2–7%

Dimensional Specifications

Each vial size designation (e.g., 2R, 6R, 10R, 20R, 50R) has precise dimensional requirements:

DesignationNominal CapacityExternal DiameterOverall Height
2R2 ml16.0 ± 0.20 mm35.0 ± 0.50 mm
6R6 ml22.0 ± 0.20 mm40.0 ± 0.50 mm
10R10 ml24.0 ± 0.20 mm45.0 ± 0.50 mm
20R20 ml30.0 ± 0.20 mm55.0 ± 0.50 mm
50R50 ml43.5 ± 0.30 mm73.0 ± 0.75 mm

These tight tolerances ensure:

  • Proper stopper seating and seal integrity
  • Compatibility with automated filling equipment
  • Consistent labeling and packaging

Neck Finish (Crimp Seal Type)

The standard specifies two primary neck finishes:

  • 13mm crimp for vials ≤ 5ml
  • 20mm crimp for vials > 5ml

The neck finish dimensions are critical for:

  • Stopper compression and seal integrity
  • Aluminum seal crimping force
  • Container-closure integrity testing (CCIT) results

Hydrolytic Resistance Testing

ISO 8362-1 references ISO 720 (surface test) and ISO 719 (grain test) for verifying glass quality:

Surface Test (ISO 720):

  • Fill vials with purified water
  • Autoclave at 121°C for 60 minutes
  • Titrate extracted alkali
  • Type I glass: ≤ 1.0 ml 0.01M HCl per 100 ml

Grain Test (ISO 719):

  • Crush glass to specified particle size
  • Boil in purified water for 30 minutes
  • Titrate extracted alkali
  • Type I glass: ≤ 1.0 ml 0.01M HCl per gram

Why ISO 8362-1 Compliance Matters

1. Patient Safety

Non-compliant vials may:

  • Release alkali that destabilizes drug formulations
  • Have dimensional defects causing stopper leakage
  • Contain glass particles from delamination
  • Fail under sterilization conditions

2. Regulatory Requirements

  • FDA requires container-closure systems to be "suitable for intended use"
  • USP <660> (Containers — Glass) references ISO standards
  • cGMP requires documented evidence of component quality
  • State boards of pharmacy may audit packaging documentation

3. Operational Reliability

  • Consistent dimensions ensure automated filling accuracy
  • Proper neck finish prevents seal failures
  • Thermal shock resistance supports autoclaving
  • Low particulate counts reduce rejection rates

How to Verify Supplier Compliance

When evaluating a vial supplier, request:

  1. Certificate of Analysis (COA) for each lot showing:

    • Dimensional measurements
    • Hydrolytic resistance results
    • Visual inspection results
    • Particulate counts (for RTU vials)
  2. ISO 8362-1 declaration of conformity from the manufacturer

  3. TSE/BSE certificate confirming no animal-derived materials

  4. Drug Master File (DMF) reference number (if applicable)

  5. Stability data demonstrating compatibility with your specific formulations

Common Non-Compliance Issues

Watch for these red flags:

  • Suppliers who cannot provide ISO 8362-1 COAs
  • Vials with visible cosmetic defects (bubbles > 1mm, scratches)
  • Dimensional variations exceeding standard tolerances
  • Glass delamination (flaking) after sterilization
  • Inconsistent neck finish causing seal failures

Conclusion

ISO 8362-1 compliance is the foundation of safe pharmaceutical packaging. Every vial that enters your cleanroom should have documented evidence of conformity to this standard. Working with a supplier who understands these requirements — and can provide complete documentation — protects your patients, your license, and your business.


All Core Distro glass vials are manufactured to ISO 8362-1:2018 standards with full COA documentation, TSE/BSE certificates, and dimensional verification reports included with every shipment. Request documentation samples.

Stay Informed

Get the latest insights on compounding pharmacy regulations, packaging innovations, and industry best practices delivered to your inbox.

No spam. Unsubscribe anytime. We respect your privacy.